Andera Partners at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Andera Partners takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions centre on building a competitive European biotech community and on the outlook for biotechs that recently went public. The IPO session, shared with HealthCap and Agomab Therapeutics, asks what comes next for that class of companies.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
Andera Partners Paris, France | |
Private equity firm whose life sciences team invests in biotech and medtech companies through its BioDiscovery funds. | Keynote Mon Nov 9 12:00–12:45 Building a competitive and impactful European biotech community: Perspectives from the European Life Sciences Coalition and CEOs How Europe can keep biotech talent, money and companies at home by drawing in big investors, speeding regulation and building stronger stock markets. Ecosystem InnovationBusiness of Biotech Panel Mon Nov 9 14:00–14:45 Voices from the IPO Class of ’25/’26: What’s Next? Leaders of biotechs that listed on the stock market in 2025 and 2026 describe life after going public and the hurdles they face. |
Instantly find 20 buyers from Andera Partners
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction